Swedish Orphan Biovitrum AB (publ) (SOBI.ST)
SEK 310.4
(-0.06%)
SEK 310.4
(-0.06%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 7.47 SEK | -12.32% |
| 2022 | 8.52 SEK | -1.73% |
| 2021 | 8.67 SEK | -17.59% |
| 2020 | 10.52 SEK | -2.41% |
| 2019 | 10.78 SEK | 20.72% |
| 2018 | 8.93 SEK | 109.13% |
| 2017 | 4.27 SEK | 42.81% |
| 2016 | 2.99 SEK | 1145.83% |
| 2015 | 0.24 SEK | 123.76% |
| 2014 | -1.01 SEK | -188.57% |
| 2013 | -0.35 SEK | 7.89% |
| 2012 | -0.38 SEK | -642.86% |
| 2011 | 0.07 SEK | 113.21% |
| 2010 | -0.53 SEK | -282.76% |
| 2009 | 0.29 SEK | 109.67% |
| 2008 | -3.00 SEK | -484.62% |
| 2007 | 0.78 SEK | -13.33% |
| 2006 | 0.90 SEK | -47.98% |
| 2005 | 1.73 SEK | 765.38% |
| 2004 | -0.26 SEK | -107.16% |
| 2003 | 3.63 SEK | 1137.14% |
| 2002 | -0.35 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 2.35 SEK | -22.19% |
| 2024 Q2 | 0.66 SEK | -71.91% |
| 2024 Q3 | 4.27 SEK | 546.97% |
| 2023 Q2 | 0.71 SEK | -79.36% |
| 2023 Q4 | 3.02 SEK | 906.67% |
| 2023 Q3 | 0.30 SEK | -57.75% |
| 2023 Q1 | 3.44 SEK | -23.04% |
| 2023 FY | - SEK | -12.32% |
| 2022 Q3 | 1.51 SEK | 73.56% |
| 2022 Q4 | 4.47 SEK | 196.03% |
| 2022 Q2 | 0.87 SEK | -52.46% |
| 2022 FY | - SEK | -1.73% |
| 2022 Q1 | 1.83 SEK | -56.43% |
| 2021 Q1 | 2.36 SEK | -53.63% |
| 2021 Q4 | 4.20 SEK | 162.5% |
| 2021 Q3 | 1.60 SEK | 75.82% |
| 2021 Q2 | 0.91 SEK | -61.44% |
| 2021 FY | - SEK | -17.59% |
| 2020 Q3 | 0.94 SEK | -2.08% |
| 2020 Q1 | 4.02 SEK | -12.99% |
| 2020 Q2 | 0.96 SEK | -76.12% |
| 2020 FY | - SEK | -2.41% |
| 2020 Q4 | 5.09 SEK | 441.49% |
| 2019 Q3 | 1.84 SEK | 8.24% |
| 2019 Q4 | 4.62 SEK | 151.09% |
| 2019 FY | - SEK | 20.72% |
| 2019 Q1 | 3.14 SEK | 42.08% |
| 2019 Q2 | 1.70 SEK | -45.86% |
| 2018 FY | - SEK | 109.13% |
| 2018 Q3 | 2.31 SEK | -9.06% |
| 2018 Q2 | 2.54 SEK | 32.98% |
| 2018 Q4 | 2.21 SEK | -4.33% |
| 2018 Q1 | 1.91 SEK | 43.61% |
| 2017 FY | - SEK | 42.81% |
| 2017 Q4 | 1.33 SEK | 10.83% |
| 2017 Q3 | 1.20 SEK | 21.21% |
| 2017 Q2 | 0.99 SEK | 32.0% |
| 2017 Q1 | 0.75 SEK | 102.7% |
| 2016 FY | - SEK | 1145.83% |
| 2016 Q3 | 0.50 SEK | -56.9% |
| 2016 Q1 | 1.12 SEK | 3578.26% |
| 2016 Q2 | 1.16 SEK | 3.57% |
| 2016 Q4 | 0.37 SEK | -26.0% |
| 2015 Q3 | 0.02 SEK | 300.0% |
| 2015 FY | - SEK | 123.76% |
| 2015 Q1 | 0.28 SEK | 528.13% |
| 2015 Q4 | -0.03 SEK | -261.0% |
| 2015 Q2 | -0.01 SEK | -103.57% |
| 2014 Q4 | -0.07 SEK | -132.7% |
| 2014 FY | - SEK | -188.57% |
| 2014 Q3 | 0.20 SEK | 100.0% |
| 2014 Q2 | 0.10 SEK | 108.2% |
| 2014 Q1 | -1.22 SEK | -2306.31% |
| 2013 Q2 | -0.04 SEK | 10.65% |
| 2013 Q1 | -0.05 SEK | 91.48% |
| 2013 Q4 | -0.05 SEK | 75.86% |
| 2013 FY | - SEK | 7.89% |
| 2013 Q3 | -0.21 SEK | -410.95% |
| 2012 Q3 | -0.17 SEK | 34.62% |
| 2012 Q4 | -0.54 SEK | -217.65% |
| 2012 FY | - SEK | -642.86% |
| 2012 Q1 | 0.58 SEK | 1203.37% |
| 2012 Q2 | -0.26 SEK | -144.83% |
| 2011 Q2 | 0.50 SEK | 256.25% |
| 2011 Q3 | -0.14 SEK | -128.0% |
| 2011 FY | - SEK | 113.21% |
| 2011 Q4 | 0.04 SEK | 131.79% |
| 2011 Q1 | -0.32 SEK | -488.24% |
| 2010 FY | - SEK | -282.76% |
| 2010 Q1 | -0.30 SEK | -207.14% |
| 2010 Q2 | -0.06 SEK | 81.6% |
| 2010 Q4 | -0.05 SEK | 58.15% |
| 2010 Q3 | -0.13 SEK | -135.51% |
| 2009 Q3 | 0.07 SEK | -52.27% |
| 2009 Q1 | -0.21 SEK | 0.0% |
| 2009 Q4 | 0.28 SEK | 291.06% |
| 2009 FY | - SEK | 109.67% |
| 2009 Q2 | 0.15 SEK | 171.43% |
| 2008 FY | - SEK | -484.62% |
| 2007 FY | - SEK | -13.33% |
| 2006 FY | - SEK | -47.98% |
| 2005 FY | - SEK | 765.38% |
| 2004 FY | - SEK | -107.16% |
| 2003 FY | - SEK | 1137.14% |
| 2002 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AcuCort AB | -0.16 SEK | 4768.75% |
| AlzeCure Pharma AB (publ) | -0.60 SEK | 1345.0% |
| BioGaia AB (publ) | 3.62 SEK | -106.354% |
| Enzymatica AB (publ) | -0.28 SEK | 2767.857% |
| Enorama Pharma AB (publ) | -1.61 SEK | 563.975% |
| Gabather AB (publ) | -0.65 SEK | 1249.231% |
| Klaria Pharma Holding AB (publ.) | -0.36 SEK | 2175.0% |
| Moberg Pharma AB (publ) | -1.33 SEK | 661.654% |
| Nanexa AB (publ) | -1.09 SEK | 785.321% |
| Newbury Pharmaceuticals AB (publ) | -0.72 SEK | 1137.5% |
| ODI Pharma AB | 0.02 SEK | -31823.077% |
| Orexo AB (publ) | -3.73 SEK | 300.268% |
| Probi AB (publ) | 1.48 SEK | -404.73% |
| Swedencare AB (publ) | 0.37 SEK | -1918.919% |
| Toleranzia AB | -0.06 SEK | 13439.286% |
| Vivesto AB | -0.74 SEK | 1109.459% |